Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.41 USD | -0.43% | -1.07% | +32.62% |
Financials (USD)
Sales 2024 * | 270M | Sales 2025 * | 120M | Capitalization | 1.78B |
---|---|---|---|---|---|
Net income 2024 * | 77M | Net income 2025 * | 2M | EV / Sales 2024 * | 4.97 x |
Net cash position 2024 * | 442M | Net cash position 2025 * | 677M | EV / Sales 2025 * | 9.24 x |
P/E ratio 2024 * |
26.4
x | P/E ratio 2025 * |
-30.9
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | -0.43% | ||
1 week | -1.07% | ||
Current month | +21.11% | ||
1 month | +20.91% | ||
3 months | +2.98% | ||
6 months | +76.49% | ||
Current year | +32.62% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 30.41 | -0.43% | 355,501 |
24-05-23 | 30.54 | -3.69% | 651,987 |
24-05-22 | 31.71 | 0.00% | 571,832 |
24-05-21 | 31.71 | +1.44% | 327,288 |
24-05-20 | 31.26 | +1.69% | 290,664 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.62% | 1.78B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.55% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- PTGX Stock